Collegium Pharmaceutical, Inc. (COLL) return on equity (ROE)

Return on equity · fiscal 2025
20.8%

Collegium Pharmaceutical, Inc. (COLL) earned a return on equity of 20.8% in fiscal 2025 (the year ended December 31, 2025). That is 9.4 percentage points lower than the 30.2% of fiscal 2024. Figures as of 17 Nov 2026, 21:51 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
20.8%
Change on fiscal 2024
−9.4 pts
Highest on record
35.2%fiscal 2021
Lowest on record
-71.9%fiscal 2017
Fiscal years on record
112015–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Collegium Pharmaceutical, Inc. return on equity (ROE), in more detail

Across the 11 fiscal years on record (2015–2025), the highest was 35.2% in fiscal 2021 and the lowest -71.9% in fiscal 2017. The fiscal 2025 figure is higher than in 70% of the 10 earlier fiscal years on record, whose median is -19.4%.

History · 11 fiscal years

Return on equity by fiscal year

Collegium Pharmaceutical, Inc. return on equity (ROE), year by year

Collegium Pharmaceutical, Inc. (COLL) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202520.8% 9.4 pts down
202430.2% 5.6 pts up
202324.6% 37.5 pts up
2022-12.8% 48.1 pts down
202135.2% 20.9 pts up
202014.4% 40.4 pts up
2019-26.0% 16.7 pts up
2018-42.7% 29.2 pts up
2017-71.9% 2.1 pts down
2016-69.8% 37.8 pts down
2015-32.0%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on COLL

Collegium Pharmaceutical, Inc., figure by figure

Collegium Pharmaceutical, Inc. (COLL) overview: price, valuation and scorecard

Collegium Pharmaceutical, Inc. return on equity (ROE): questions and answers

What is Collegium Pharmaceutical, Inc.'s return on equity?

Collegium Pharmaceutical, Inc. (COLL) earned a return on equity of 20.8% in fiscal 2025 (the year ended December 31, 2025). That is 9.4 percentage points lower than the 30.2% of fiscal 2024.

Is Collegium Pharmaceutical, Inc.'s return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 70% of the 10 earlier fiscal years on record, whose median is -19.4%.

What are the highest and lowest return on equity figures on record for Collegium Pharmaceutical, Inc.?

Across the 11 fiscal years on record (2015–2025), the highest was 35.2% in fiscal 2021 and the lowest -71.9% in fiscal 2017.

How is Collegium Pharmaceutical, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Collegium Pharmaceutical, Inc. (COLL) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/COLL/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.